Gilead Sciences

This study tested a new drug called magrolimab combined with other cancer treatments for people with head and neck squamous cell carcinoma that had spread or come back. The goal was to see if the combination was safe and effective. The trial was stopped early, so results are limi…

This study tested a new experimental HIV medicine, GS-1219, in a small group of 4 people living with HIV-1. The goal was to check if the drug is safe and how well it lowers the amount of virus in the blood. The study was stopped early, so results are very limited.

This study tested whether a new once-weekly oral drug combination (lepetegravir and lenacapavir pacfosacil) could control HIV as well as the daily pill Biktarvy in people who had never taken HIV medication before. The trial was terminated early, so results are limited. It involve…

This study tested an experimental drug called GS-5718 for people with cutaneous lupus erythematosus (CLE), a condition that causes painful skin rashes and sores. Researchers wanted to see if the drug could reduce skin disease activity and improve symptoms. The study was stopped e…

This study tested a drug called magrolimab combined with chemotherapy for people with advanced triple-negative breast cancer that cannot be removed by surgery. The goal was to see if the combination was safe and worked better than chemotherapy alone. The trial was stopped early, …